NCT04906434 2025-11-12
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
Abbisko Therapeutics Co, Ltd
Phase 1 Recruiting
Abbisko Therapeutics Co, Ltd
Binhui Biopharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Guangxi Medical University